Gf Fund Management Co. Ltd. Alnylam Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,302 shares of ALNY stock, worth $869,218. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,302
Previous 2,708
21.94%
Holding current value
$869,218
Previous $637 Million
39.92%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ALNY
# of Institutions
686Shares Held
109MCall Options Held
839KPut Options Held
765K-
Capital World Investors Los Angeles, CA16.6MShares$4.37 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.35 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.51 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.83 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.15 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $32.4B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...